NFJ Investment Group LLC Increases Stake in LivaNova PLC (NASDAQ:LIVN)

NFJ Investment Group LLC lifted its holdings in shares of LivaNova PLC (NASDAQ:LIVN) by 104.1% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 96,400 shares of the company’s stock after purchasing an additional 49,176 shares during the period. NFJ Investment Group LLC owned about 0.18% of LivaNova worth $5,065,000 as of its most recent filing with the SEC.

Other large investors also recently added to or reduced their stakes in the company. Fifth Third Bancorp grew its stake in shares of LivaNova by 97.1% during the second quarter. Fifth Third Bancorp now owns 674 shares of the company’s stock valued at $37,000 after buying an additional 332 shares during the last quarter. Hexagon Capital Partners LLC grew its position in LivaNova by 117.8% during the 2nd quarter. Hexagon Capital Partners LLC now owns 684 shares of the company’s stock worth $37,000 after acquiring an additional 370 shares during the last quarter. Canada Pension Plan Investment Board purchased a new position in LivaNova in the 2nd quarter worth approximately $88,000. Central Pacific Bank Trust Division purchased a new position in LivaNova in the 3rd quarter worth approximately $178,000. Finally, TradeLink Capital LLC bought a new stake in LivaNova in the second quarter valued at approximately $208,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently commented on LIVN shares. Baird R W raised shares of LivaNova from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, September 17th. Mizuho decreased their price objective on shares of LivaNova from $80.00 to $70.00 and set an “outperform” rating on the stock in a research report on Thursday, October 31st. The Goldman Sachs Group assumed coverage on LivaNova in a research note on Friday, October 4th. They issued a “buy” rating and a $65.00 target price on the stock. Needham & Company LLC reaffirmed a “buy” rating and set a $75.00 price target on shares of LivaNova in a research report on Monday, November 25th. Finally, Robert W. Baird increased their price objective on LivaNova from $66.00 to $72.00 and gave the stock an “outperform” rating in a report on Thursday, October 31st. One research analyst has rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of “Buy” and an average price target of $69.17.

LivaNova Stock Performance

Shares of LIVN opened at $51.62 on Wednesday. The company has a 50-day simple moving average of $52.29 and a two-hundred day simple moving average of $51.95. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.37 and a quick ratio of 2.87. The firm has a market capitalization of $2.80 billion, a PE ratio of 122.90 and a beta of 0.98. LivaNova PLC has a one year low of $42.75 and a one year high of $64.47.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.